

Health Library
October 10, 2025
Question on this topic? Get an instant answer from August.
I-Amivantamab ngumuthi womdlavuza oqondiswe ngqo osiza ukwelapha izinhlobo ezithile zomdlavuza wamaphaphu. Kuyindlela yokwelapha ekhethekile eyenzelwe ukuvimba amaprotheni athile asiza amaseli omdlavuza ukuthi akhule futhi asakazeke emzimbeni wakho wonke.
Lo muthi ungowodidi olusha lwezindlela zokwelapha umdlavuza olubizwa ngokuthi ama-antibody e-bispecific. Cabanga ngayo njengethuluzi eliqondile eliqondise izindlela ezimbili ezihlukene amaseli omdlavuza azisebenzisa ukuze asinde, kunokuthinta wonke amaseli ahlukana ngokushesha njengoba kwenza i-chemotherapy yendabuko.
I-Amivantamab iphatha abantu abadala abanomdlavuza wamaphaphu ongahlobene namaseli amancane (NSCLC) onoshintsho oluthile lofuzo. Udokotela wakho uzo-oda izivivinyo ezikhethekile ukuze anqume ukuthi umdlavuza wakho unazo yini izici ezifanele zokuthi le ndlela yokwelapha isebenze ngempumelelo.
Lo muthi uqondise ngqo imidlava yomdlavuza wamaphaphu enoshintsho lofuzo lwe-EGFR exon 20 insertion. Lokhu kuyizinguquko ezithile zofuzo ezenza amaseli omdlavuza akhule ngendlela ehlukile kunezinye izinhlobo zomdlavuza wamaphaphu. Udokotela wakho we-oncologist uzokuchazela ukuthi ngabe uhlobo lomdlavuza wakho oluthile luyahambisana yini nalokho okungelashwa yilo muthi.
Le ndlela yokwelapha ivamise ukusetshenziswa lapho umdlavuza wakho usakazekele kwezinye izingxenye zomzimba wakho noma lapho ukwelashwa kwangaphambilini kungasebenzi kahle njengoba bekulindelekile. Ithimba lakho lezokwelapha lizohlola ngokucophelela impilo yakho yonke kanye nezici zomdlavuza ngaphambi kokuncoma le nketho.
I-Amivantamab isebenza ngokuvimba amaprotheni amabili abalulekile adingwa amaseli omdlavuza ukuze akhule futhi asinde. Iqondise kokubili ama-receptor e-EGFR kanye ne-MET, afana nokushintsha okutshela amaseli omdlavuza ukuthi aphindaphindeke futhi asakazeke.
Lo muthi ubhekwa njengokwelapha umdlavuza okuphakathi nendawo. Uqondiswe kakhulu kune-chemotherapy yendabuko, okusho ukuthi ugxila ngqo kumaseli omdlavuza kunokuthinta wonke amaseli akhula ngokushesha emzimbeni wakho. Le ndlela eqondile ingaholela emiphumeleni emincane uma iqhathaniswa nokwelashwa okuvamile.
Lo muthi futhi uvula amasosha akho omzimba ukuthi asize ukulwa nomdlavuza. Usebenza njengebhuloho, exhuma amaseli omzimba akho okuvikela emzimbeni kumaseli omdlavuza, okwenza kube lula ngamasosha akho omzimba ukuqaphela nokuhlasela umdlavuza.
I-Amivantamab inikezwa njenge-intravenous (IV) infusion ngqo egazini lakho esikhungweni sokwelapha umdlavuza noma esibhedlela. Awukwazi ukuthatha lo muthi ekhaya, njengoba kudinga ukuqashwa ngokucophelela ochwepheshe bezempilo abaqeqeshiwe.
Ngaphambi kwe-infusion ngayinye, ithimba lakho lezokwelapha lizokunika imithi yangaphambi kokwelashwa ukusiza ukuvimbela ukusabela komzimba. Lokhu kuvame ukuhlanganisa ama-antihistamines, ama-steroids, kanye nezinto ezinciphisa umkhuhlane. Uzowathola lawa malungiselelo cishe imizuzu engama-30 kuya kwengama-60 ngaphambi kokuthi ukwelashwa kwakho nge-amivantamab kuqale.
Inqubo ye-infusion ngokuvamile ithatha amahora amaningana ngesikhathi sokwelashwa kwakho kokuqala, njengoba ithimba lakho lezempilo lizokwenza kancane kancane futhi lenyuse izinga uma ukubekezelela kahle. Ukwelashwa okulandelayo kungaba kufushane uma umzimba wakho ujwayela umuthi.
Akudingeki ukuthi uzile ukudla ngaphambi kokwelashwa, kodwa ukudla ukudla okulula ngaphambi kwesikhathi kungakusiza ukuthi uzizwe ukhululekile ngesikhathi senqubo ende ye-infusion. Hlala unamanzi ngokwanele ngokuphuza amanzi amaningi ezinsukwini eziholela ekwelashweni kwakho.
Ubude bokwelashwa nge-amivantamab buhlukahluka kakhulu kumuntu nomuntu, kuye ngokuthi umdlavuza wakho uphendula kahle kangakanani nokuthi uwubekezelela kanjani umuthi. Abanye abantu baqhubeka nokwelashwa izinyanga eziningi, kanti abanye bangase badinge ukuyeka ngaphambi kwesikhathi ngenxa yemiphumela emibi noma ukuqhubeka kwesifo.
Udokotela wakho we-oncologist uzoqapha intuthuko yakho ngokusebenzisa izithombe ezivamile kanye nokuhlolwa kwegazi ukuze anqume ukuthi ukwelashwa kusebenza ngempumelelo yini. Lokhu kuhlolwa kusiza ithimba lakho lezokwelapha ukuthi linqume ukuthi liqhubeke, lilungise, noma lishintshe uhlelo lwakho lokwelashwa.
Ukwelashwa kuvame ukuqhubeka uma nje umdlavuza wakho uzinzile noma unciphisa futhi ungaqali ukuzwa imiphumela emibi kakhulu. Uma umdlavuza uqala ukukhula futhi noma uma imiphumela emibi iba nzima kakhulu ukuyilawula, udokotela wakho uzoxoxa ezinye izinketho zokwelashwa nawe.
Njengoba kuningi ukwelashwa komdlavuza, i-amivantamab ingabangela imiphumela emibi, nakuba kungewona wonke umuntu oyitholayo ngendlela efanayo. Abantu abaningi bayakwazi ukumelana nalolu hlobo lomuthi kahle, ikakhulukazi uma kuqhathaniswa ne-chemotherapy yendabuko.
Imiphumela emibi evame kakhulu ongase uyithole ihlanganisa ukusabela kwesikhumba, izinguquko zezipikili, kanye nezinkinga zokugaya ukudla. Ukuqonda ukuthi yini ongayilindela kungakusiza ukuthi ulungiselele futhi wazi ukuthi ungalithinta nini ithimba lakho lezempilo ukuze uthole ukwesekwa.
Nansi imiphumela emibi ongase uhlangabezane nayo:
Le miphumela emibi ejwayelekile ivame ukulawuleka ngokunakekelwa okusekelayo kanye nemithi udokotela wakho angayinquma. Abantu abaningi bathola ukuthi imiphumela emibi iba ngcono njengoba umzimba wabo ujwayela ukwelashwa.
Nakuba kungavamile, abanye abantu bangase bathole imiphumela emibi engathi sína edinga ukunakekelwa kwezempilo ngokushesha. Lezi zinkinga ezingavamile kodwa ezibalulekile zingahlanganisa:
Uma uhlangabezana nanoma yiziphi zalezi zimpawu ezinzima, xhumana nethimba lakho lezempilo ngokushesha noma uye egumbini eliphuthumayo. Ithimba lakho lezokwelapha lizokunikeza imiyalelo enemininingwane mayelana nokuthi yiziphi izimpawu ezidinga ukunakwa okuphuthumayo.
I-Amivantamab ayifanele wonke umuntu, futhi i-oncologist yakho izohlola ngokucophelela ukuthi ingabe iyona ndlela efanele esimweni sakho esithile. Izici eziningana zithonya ukuthi le mithi ilungele yini wena.
Akufanele uthole i-amivantamab uma uke waba nokusabela okukhulu komzimba kule mithi noma kunoma yiziphi izithako zayo esikhathini esidlule. Udokotela wakho uzoxoxa ngomlando wakho wokungezwani komzimba ngokucophelela ngaphambi kokuqala ukwelashwa.
Abantu abanezimo ezithile zenhliziyo, isifo samaphaphu esibi, noma izifo ezisebenzayo bangase badinge ukwelashwa okuhlukile noma ukuqapha okwengeziwe. Ithimba lakho lezokwelapha lizobuyekeza umlando wakho wezokwelapha ophelele ukuze liqinisekise ukuthi lokhu kwelashwa kuphephile kuwe.
Uma ukhulelwe noma uhlela ukukhulelwa, i-amivantamab ayinconywa njengoba ingalimaza ingane yakho ekhulayo. Abesifazane abaneminyaka yokuzala kufanele basebenzise izindlela zokulawula inzalo ezisebenzayo ngesikhathi sokwelashwa kanye nasezinyangeni ezimbalwa ngemva kwalokho.
I-Amivantamab itholakala ngaphansi kwegama lomkhiqizo elithi Rybrevant. Leli yigama lomkhiqizo elilodwa elitholakala njengamanje kule mithi e-United States nakwamanye amazwe amaningi.
Inkampani yakho yomshuwalense nekhemisi zizoyibona imithi ngegama layo elivamile (amivantamab) noma ngegama lomkhiqizo (Rybrevant). Womabili la magama abhekisela emuthini ofanayo, ngakho ungakhathazeki uma ubona elinye lawo emarekhodini akho ezokwelapha noma emaphepheni okwelashwa.
Uma i-amivantamab ingakulungele noma iyeka ukusebenza ngempumelelo, ezinye izinketho zokwelapha zingase zitholakale. Enye indlela engcono kakhulu incike ohlotsheni lwakho oluthile lomdlavuza wamaphaphu kanye nokwelashwa okutholile ngaphambilini.
Ezinye izindlela zokwelapha ezihloswe ngqo ngomdlavuza wamaphaphu one-EGFR-positive zihlanganisa imithi efana ne-osimertinib, erlotinib, noma afatinib. Kodwa-ke, lezi zisebenza ngendlela ehlukile kune-amivantamab futhi zingase zingasebenzi ngezinguquko ezifanayo zofuzo.
Izinhlanganisela zokwelapha ngamakhemikhali zendabuko zihlala ziyizinketho ezibalulekile zokwelapha, ikakhulukazi lapho izindlela zokwelapha ezihloswe ngqo zingasasebenzi. Imithi yokwelapha ngomzimba njenge-pembrolizumab noma i-nivolumab nayo ingase icatshangelwe, kuye ngezici zomdlavuza wakho.
Udkt wakho wezifo zomdlavuza uzoxoxa ngezinketho ezitholakalayo nawe, ecabangela izici ezithile zomdlavuza wakho, impilo yakho yonke, kanye nezintandokazi zakho zokwelashwa.
I-Amivantamab inikeza izinzuzo eziyingqayizivele uma iqhathaniswa nezinye izithiyo ze-EGFR, ikakhulukazi ezinhlotsheni ezithile zokuguquka komdlavuza wamaphaphu. Yenzelwe ukusebenza ngokumelene nokufakwa kwe-EGFR exon 20, okungaphenduli kahle ezithiyweni ezindala ze-EGFR ezifana ne-erlotinib noma i-gefitinib.
Inzuzo enkulu ye-amivantamab yindlela yayo yokuhlosela kabili. Ngenkathi izithiyo ze-EGFR zendabuko zigxila endleleni eyodwa yamaprotheni, i-amivantamab ivimba zombili izamukeli ze-EGFR ne-MET, okungenzeka ukuthi ikwenze kusebenze ngempumelelo kumangqamuzana omdlavuza amelana nawo.
Noma kunjalo, "ngcono" kuncike esimweni sakho esithile. Abanye abantu bangase babe nemiphumela emincane emibi ngama-inhibitors e-oral EGFR, kanti abanye basabela kangcono endleleni eqondiswe ngqo ye-amivantamab. Udokotela wakho we-oncologist uzosiza ekunqumeni ukuthi yikuphi ukwelashwa okunikeza ukulinganisela okungcono kakhulu kokusebenza kahle nokubekezeleleka esimweni sakho somuntu ngamunye.
I-Amivantamab ingasetshenziswa kubantu abanezifo zenhliziyo, kodwa idinga ukuqapha nokuhlola okucophelelayo. Udokotela wakho we-cardiologist kanye ne-oncologist bazosebenzisana ukuhlola ukuthi izinzuzo zidlula yini izingozi zesimo sakho senhliziyo esithile.
Ngaphambi kokuqala ukwelashwa, cishe uzodinga izivivinyo zomsebenzi wenhliziyo okuhlanganisa i-echocardiogram noma i-MUGA scan. Ithimba lakho lezokwelapha lizogada impilo yenhliziyo yakho kuyo yonke inkathi yokwelashwa futhi lingashintsha uhlelo lwakho lokunakekelwa uma kuvela noma yiziphi izinkathazo.
Uma uphuthelwa ukufakwa kwakho kwe-amivantamab okuhleliwe, xhumana nesikhungo sakho sokwelashwa umdlavuza ngokushesha ngangokunokwenzeka ukuze uhlele kabusha. Ungakhathazeki kakhulu ngokulahlekelwa ukwelashwa okukodwa, njengoba ithimba lakho lezokwelapha lingashintsha uhlelo lwakho ngokuphepha.
Ithimba lakho lezempilo lizinquma isikhathi esingcono kakhulu somthamo wakho olandelayo ngokusekelwe ekutheni sekudlule isikhathi esingakanani kusukela ekwelashweni kwakho kokugcina. Kungase kudingeke ukuthi balungise imithi yakho yangaphambi kokwelashwa noma uhlelo lokuqapha, kodwa ukuphuthelwa umthamo owodwa ngokuvamile akulihambisi phambili uhlelo lwakho lokwelashwa olujwayelekile.
Uma uthola imiphumela emibi kakhulu ngesikhathi sokufakwa kwakho kwe-amivantamab, tshela ithimba lakho lezempilo ngokushesha. Baqeqeshwe ukubhekana nokusabela kokufakwa futhi banemithi elungele ukusiza ukuphatha noma yiziphi izinkinga ezingase zivele.
Ukufakwa kungancishiswa, kumiswe okwesikhashana, noma kumiswe ngokuphelele kuye ngezimpawu zakho. Ithimba lakho lezokwelapha lingakunika imithi eyengeziwe ukukusiza ukulawula ukusabela futhi kukwenze uzizwe ukhululekile.
Ungayeka ukuthatha i-amivantamab lapho i-oncologist yakho inquma ukuthi ayisazuzi noma uma uhlangabezana nemiphumela emibi ethinta kakhulu izinga lempilo yakho. Lesi sinqumo senziwa ngaso sonke isikhathi ngokubambisana phakathi kwakho nethimba lakho lezempilo.
Izizathu zokumisa ukwelashwa zingabandakanya ukuqhubeka komdlavuza naphezu kokwelashwa, ukuthuthukiswa kwemiphumela emibi enzima, noma uma unquma ukuthi umthwalo wokwelashwa udlula izinzuzo. Udokotela wakho uzoxoxa ngazo zonke izinketho nawe futhi akusize ukuthi wenze isinquumo esingcono kakhulu sesimo sakho.
Ukuya ohambeni ngesikhathi sokwelashwa kwe-amivantamab kungenzeka, kodwa kudinga ukuhlela ngokucophelela nokuxhumana nethimba lakho lezempilo. Kuzodingeka uqinisekise ukuthi ungathola ukufakwa kwakho okuhleliwe futhi ufinyelele ekunakekelweni kwezempilo uma kudingeka.
Ngaphambi kokuhamba, xoxa ngezinhlelo zakho ne-oncologist yakho. Bangakunikeza amarekhodi ezokwelapha, imininingwane yokuxhumana yabahlinzeki bezempilo lapho uya khona, kanye nesiqondiso sokulawula imiphumela emibi engaba khona ngenkathi ungekho ekhaya.
6Mpeople
Get clear medical guidance
on symptoms, medications, and lab reports.